Evaluation of the effects of commonly used α2-adrenergic receptor agonists alone and in combination with butorphanol tartrate on objective measurements of lameness in horses

This is the authors' abstract. We don't add key points for this paper.

In the study horses, xylazine alone had the least impact on objective lameness measurements. The administration of α₂-ARAs, particularly detomidine or romifidine, alone or in combination with butorphanol, resulted in small but significant effects on objective lameness measurements.